Three IPOs and one SPAC priced this week, while two IPOs and five SPACs submitted filings.
China-based Londian Wason New Energy Tech (FOIL) priced its upsized US IPO at the top of the range to raise $94 million at a market cap of $1.7 billion ($3.1 billion enterprise value). Londian Wason calls itself the world’s largest supplier of copper foil for lithium-ion batteries in terms of sales volumes in 2025, and is a major supplier of PCB-grade copper foil. Its products are found in electric vehicles, energy storage systems, and a variety of downstream applications such as consumer electronics. Investors led by China’s Harvest Fund Management have together indicated on $87 million worth of ADSs, or about 92% of the offering. Londian Wason New Energy Tech finished the week up 10%.
Metabolic disorder biotech Vogenx (VOGX) priced at the top of the range to raise $81 million at a $187 million market cap. Vogenx’s initial focus is on post-bariatric hypoglycemia (PBH) and gastroparesis. Its lead candidate, mizagliflozin, is an oral, selective SGLT1 inhibitor licensed from Kissei Pharmaceutical. Mizagliflozin has been studied in more than 500 subjects across 10 clinical trials. The company expects to begin screening patients this year for a Phase 2b trial in PBH and is also planning a Phase 2 proof of concept trial in gastroparesis for 2027. Vogenx finished the week up 14%.
New Zealand solar-powered mower maker SunScout Holding (SNSC) priced its downsized US IPO at the bottom of the range to raise $16 million at a $191 million market cap. SunScout Holding develops and manufactures autonomous robotic lawn mowers powered by integrated solar energy systems. Its products are designed to operate independently of both gasoline engines and grid-connected electricity by using onboard deployable solar panels to recharge batteries, eliminating the need for fixed charging stations. SinScout Holding finished the week down 39%.
The sole SPAC to price this week as Gary Simanson-led Thunder Bridge Capital V (TBCVU), which raised $261 million to target fintech.
Although it is not included below, Robinhood Ventures II (RVII), a closed-end fund formed by Robinhood to hold a portfolio of private growth companies, also debuted on the NYSE. It finished the week down 2%.
| 4 IPOs During the Week of August 10th, 2026 | |||||
|---|---|---|---|---|---|
| Issuer Business | Deal Size | Market Cap at IPO | Price vs. Midpoint | First Day Return | Return at 08/14 |
| Vogenx (VOGX) | $81M | $187M | 8% | +0% | +14% |
| Phase 2b biotech developing therapies for endocrine and metabolic disorders. | |||||
| Londian Wason (FOIL) | $94M | $1,719M | 5% | +11% | +10% |
| China-based producer of copper foils mainly used for lithium-ion batteries. | |||||
| Thunder Bridge Capital V (TBCVU) | $261M | $334M | 0% | -1% | -1% |
| Fifth blank check company led by Gary Simanson targeting the fintech industry. | |||||
| SunScout Holding (SNSC) | $16M | $191M | -9% | -39% | -39% |
| New Zealand-based developer of autonomous solar-powered mowers and other solar products. | |||||
Sign up for a free trial of our premium platform, IPO Pro. To get our IPO calendar in your inbox, register here.
Two IPOs submitted initial filings this week. Europe-focused messaging services provider Fast Finance Pay (FFPP) filed to raise $15 million at a $137 million market cap. Scarring and autoimmune disease biotech BirchBioMed (BRBM) filed for a direct listing on the Nasdaq.
Five SPACs also submitted initial filings. Gores Holdings XII (GDOZU), formed by The Gores Group, filed to raise $312 million. Inflection Point Acquisition VIII (IPHXU), led by Michael Blitzer, filed to raise $250 million to target tech-enabled businesses. GigCapital10 (GIA.U), led by SPAC veteran Avi Katz, filed to raise $220 million to target aerospace and TMT businesses. Eaglesky Acquisition (ESA.U) filed to raise $100 million to target middle market businesses. JATT III Acquisition (JTTT), formed by biotech entrepreneurs, filed to raise $60 million to target life sciences.
| 7 Filings During the Week of August 10th, 2026 | |||
|---|---|---|---|
| Issuer Business | Deal Size | Sector | Lead Underwriter |
| BirchBioMed (BRBM) | $0M | Health Care | |
| Phase 2b/3 biotech developing treatments for scarring and autoimmune diseases. | |||
| Fast Finance Pay (FFPP) | $15M | Technology | Benchmark |
| Provides emailing and messaging services, with a focus on Europe. | |||
| Eaglesky Acquisition (ESA.U) | $100M | SPAC | Maxim |
| Blank check company targeting middle market businesses. | |||
| GigCapital10 (GIA.U) | $220M | SPAC | D. Boral Capital |
| Blank check company led by SPAC veteran Avi Katz targeting aerospace and TMT businesses. | |||
| Gores Holdings XII (GDOZU) | $312M | SPAC | Santander |
| Blank check company formed by The Gores Group. | |||
| Inflection Point Acq VIII (IPHXU) | $250M | SPAC | Cohen & Company |
| Blank check company led by Michael Blitzer targeting technology-enabled businesses. | |||
| JATT III Acquisition (JTTT) | $60M | SPAC | Guggenheim |
| Blank check company formed by biotech entrepreneurs targeting life sciences businesses. | |||
Sign up for a free trial of our premium platform, IPO Pro. To get our IPO calendar in your inbox, register here.
IPO Market Snapshot
The Renaissance IPO Indices are market cap weighted baskets of newly public companies. As of 8/13/2026, the Renaissance IPO Index was up 25.6% year-to-date, while the S&P 500 was up 14.7%. Renaissance Capital's IPO ETF (NYSE: IPO) tracks the index, and top ETF holdings include CoreWeave (CRWV) and Astera Labs (ALAB). The Renaissance International IPO Index was up 41.1% year-to-date, while the ACWX was up 17.4%. Renaissance Capital’s International IPO ETF (NYSE: IPOS) tracks the index, and top ETF holdings include Galderma and CATL.
